# Smithkline Beecham (Investments) (Smithkline Beecham (Investments) Limited)

Private limited company registered in London, classed under “Financial intermediation not elsewhere classified”.

- Company number: 00302065
- Status: Active
- Type: Private limited company
- Incorporated: 21 June 1935
- Registered office: 79 New Oxford Street, London, WC1A 1DG
- Location: London
- Activity: Financial intermediation not elsewhere classified

## Latest filed profit

No profit figure in its latest filed accounts.

Turnover, net assets, cash, staff, earlier years, ratios and owners are on the page for subscribers.

## Questions people ask

### What does Smithkline Beecham (Investments) do?

Private limited company registered in London, classed under “Financial intermediation not elsewhere classified”.

### How much turnover does Smithkline Beecham (Investments) make?

Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/smithkline-beecham-investments-00302065

### Is Smithkline Beecham (Investments) profitable?

Smithkline Beecham (Investments)'s profit isn't public: small companies may file without a profit and loss account.

### Who runs and owns Smithkline Beecham (Investments)?

Its directors are Edinburgh Pharmaceutical Industries Limited, Laura Guittard, Edinburgh Pharmaceutical Industries Limited, Glaxo Group Limited. Its owners are shown to subscribers.

### Where is Smithkline Beecham (Investments) based?

Its registered office is 79 New Oxford Street, London, WC1A 1DG, in London.

### When was Smithkline Beecham (Investments) founded?

Smithkline Beecham (Investments) Limited was incorporated on 21 June 1935.

### Is Smithkline Beecham (Investments) still trading?

The register lists Smithkline Beecham (Investments) Limited as active.

## Timeline

Recent filings and changes at Companies House.

- 2026-05-24: Audit exemption subsidiary accounts made up to 31 December 2025
- 2026-05-24: Consolidated accounts of parent company for subsidiary company period ending 31/12/25
- 2026-05-24: Audit exemption statement of guarantee by parent company for period ending 31/12/25 (and 15 more like it since 24 October 2001)
- 2026-05-24: Notice of agreement to exemption from audit of accounts for period ending 31/12/25
- 2025-05-29: Audit exemption subsidiary accounts made up to 31 December 2024
- 2025-05-29: Consolidated accounts of parent company for subsidiary company period ending 31/12/24
- 2025-05-29: Notice of agreement to exemption from audit of accounts for period ending 31/12/24
- 2024-09-23: Register(s) moved to registered office address 79 New Oxford Street London WC1A 1DG
- 2024-09-23: Register(s) moved to registered inspection location
- 2024-09-17: Director's details changed for Mrs Laura Guittard on 11 September 2024
- 2024-09-11: Change of details for Smithkline Beecham Limited as a person with significant control on 11 September 2024
- 2024-09-11: Change of details for Setfirst Limited as a person with significant control on 11 September 2024
- 2024-09-11: Registered office address changed from 980 Great West Road Brentford Middlesex TW8 9GS to 79 New Oxford Street London WC1A 1DG on 11 September 2024
- 2024-07-18: Register inspection address has been changed
- 2024-05-21: Audit exemption subsidiary accounts made up to 31 December 2023
- 2024-05-21: Consolidated accounts of parent company for subsidiary company period ending 31/12/23
- 2024-05-21: Notice of agreement to exemption from audit of accounts for period ending 31/12/23
- 2023-08-22: Audit exemption subsidiary accounts made up to 31 December 2022
- 2023-08-22: Notice of agreement to exemption from audit of accounts for period ending 31/12/22
- 2023-08-16: Director's details changed for Glaxo Group Limited on 6 June 2023
- 2023-08-11: Consolidated accounts of parent company for subsidiary company period ending 31/12/22
- 2022-06-21: Audit exemption subsidiary accounts made up to 31 December 2021
- 2022-06-21: Consolidated accounts of parent company for subsidiary company period ending 31/12/21
- 2022-06-21: Notice of agreement to exemption from audit of accounts for period ending 31/12/21
- 2022-01-13: Appointment of Mrs Laura Guittard as a director on 11 January 2022

---

Source: Companies House filings (Open Government Licence v3.0). Figures are as filed; nothing is estimated. Page: https://firmfacts.co/company/smithkline-beecham-investments-00302065